Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue 2, 2010, Pages 91-95

  Molimard, Mathieu ^a,b,c   Gros, Vincent Le ^d   Robinson, Philip ^b   Bourdeix, Isabelle ^d  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d NOVARTIS PHARMA K K   (Japan)

Author keywords

Asthma; COPD; Inhaled corticosteroids; Oropharyngeal; Prevalence; Real life

Indexed keywords

BECLOMETASONE; BUDESONIDE; FLUTICASONE;

ADULT; ARTICLE; ASTHMA; BITTER TASTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHONIA; FEMALE; GENERAL PRACTITIONER; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MOUTH IRRITATION; PATIENT COMPLIANCE; PREVALENCE; REDDENING; SIDE EFFECT; SKIN DISCOMFORT; SKIN TINGLING; TASTE AVERSION; TREATMENT INDICATION;

EID: 77951106062     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2009.0762     Document Type: Article

References (22)

1. Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention 2006. Available from: http:==www.ginasthma.com.
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2007. Available from: http:==www.goldcopd.com.
3. Hanania NA, Chapman KR, Kesten S: Adverse effects of inhaled corticosteroids. Am J Med. 1995;98:196-208.
4. Passalacqua G, Albano M, Canonica GW, Bachert C, Van Cauwenberge P, Davies RJ, Durham SR, Kontou-Fili K, Horak F, Malling HJ: Inhaled and nasal corticosteroids: safety aspects. Allergy. 2000;55:16-33.
5. Vogt FC: The incidence of oral candidiasis with use of inhaled corticosteroids. Ann Allergy. 1979;43:205-210
6. Willey RF, Milne LJ, Crompton GK, Grant IW: Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest. 1976;70:32-38.
7. Toogood JH, Lefcoe NM, Haines DS, Jennings B, Errington N, Baksh L, Chuang L: A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol. 1977;59:298-308.
8. Kurt E, Yildirim H, Kiraz N, Orman A, Metintas M, Akgun Y, Erginel S: Oropharyngeal candidiasis with dry-powdered fluticasone propionate: 500 microg=day versus 200 microg= day. Allergol Immunopathol (Madr). 2008;36:17-20.
9. Toogood JH, Jennings B, Baskerville J, Anderson J, Johansson SA: Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis. 1984;65:35-44.
10. Webb DR, Mullarkey MF, Freeman MI: Flunisolide in chronic bronchial asthma. Ann Allergy. 1979;42:80-82
11. Hodson ME, Batten JC, Clarke SW, Gregg I: Beclomethasone dipropionate aerosol in asthma. Transfer of steroiddependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis. 1974;110:403-408
12. Buhl R: Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy. 2006;61:518-526
13. Williamson IJ, Matusiewicz SP, Brown PH, Greening AP, Crompton GK: Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J. 1995;8:590-592
14. Selroos O, Backman R, Forsen KO, Lofroos AB, Niemisto M, Pietinalho A, Aikas C, Riska H: Local side-effects during 4-year treatment with inhaled corticosteroids-a comparison between pressurized metered-dose inhalers and Turbuhaler. Allergy. 1994;49:888-890.
15. Krishnan JA, Riekert KA, McCoy JV, Stewart DY, Schmidt S, Chanmugam A, Hill P, Rand CS: Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med. 2004;170:1281-1285.
16. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC: Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004; 114:1288-1293.
17. Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, Huiart L: Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy. 2001;56:944-948.
18. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W: Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J. 2006;28: 1042-1050.
19. Marceau C, Lemiere C, Berbiche D, Perreault S, Blais L: Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol. 2006;118:574-581.
20. Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP: Adherence to asthma controller medication regimens. Respir Med. 2005;99:1263-1267.
21. Yokoyama H, Yamamura Y, Ozeki T, Iga T, Yamada Y: Influence of mouth washing procedures on the removal of drug residues following inhalation of corticosteroids. Biol Pharm Bull. 2006;29:1923-1925.
22. Yokoyama H, Yamamura Y, Ozeki T, Iga T, Yamada Y: Effects of mouth washing procedures on removal of budesonide inhaled by using Turbuhaler. Yakugaku Zasshi. 2007; 127:1245-1249.